Synonyms: LY-3411067 | LY3411067
Compound class:
Synthetic organic
Comment: The chemical structure for ilunocitinib was obtained from WHO Proposed list 125. This mapped to PubChem CID 44231134. Ilunocitinib appears to be an oral JAK inhibitor that is intended for veterinary use, and which is being developed by Elanco Animal Health as a therapeutic for inflammatory skin conditions.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-[1-cyclopropylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile |
International Nonproprietary Names ![]() |
|
INN number | INN |
11894 | ilunocitinib |
Synonyms ![]() |
LY-3411067 | LY3411067 |
Database Links ![]() |
|
CAS Registry No. | 1187594-14-4 (source: WHO INN record) |
GtoPdb PubChem SID | 442878696 |
PubChem CID | 44231134 |
Search Google for chemical match using the InChIKey | RVOUEXFKIYNODQ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | RVOUEXFKIYNODQ |
Search PubMed clinical trials | ilunocitinib |
Search PubMed titles | ilunocitinib |
Search PubMed titles/abstracts | ilunocitinib |
UniChem Compound Search for chemical match using the InChIKey | RVOUEXFKIYNODQ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RVOUEXFKIYNODQ-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Ilunocitinib (links to external site)
Cat. No. HY-132819 |